Your session is about to expire
← Back to Search
Letrozole for Breast Cancer
Study Summary
This trial will assess the impact of dietary omega 3 free fatty acids and/or letrozole on obese, postmenopausal breast cancer patients.
- Breast Cancer
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has Letrozole been studied in any other research studies?
"Presently, 153 trials are underway to explore the efficacy of Letrozole. Of those studies, 39 are in their final stage and based primarily in San Francisco. There are also an additional 10967 medical centres conducting research on this particular treatment."
What medical indication is Letrozole commonly prescribed for?
"Letrozole is a beneficial medication for treating breast cancer, irregular menstrual cycles, and tamoxifen resistance."
What is the scale of participation in this experiment?
"Affirmative, clinicaltrials.gov shows this trial is presently enrolling individuals. It was initially advertised on April 1st 2016 and refreshed most recently on August 25th 2022, with a goal of obtaining 60 volunteers at one site."
Are volunteers able to join this clinical experiment presently?
"Affirmative. According to the clinicaltrials.gov database, this research project is actively seeking participants since its initial posting on April 1st 2016 and most recent update on August 25th 2022. Specifically, 60 individuals are needed across one location."
Share this study with friends
Copy Link
Messenger